As of 2025-07-09, the Intrinsic Value of Oncodesign SA (ALONC.PA) is 1.72 EUR. This ALONC.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 14.42 EUR, the upside of Oncodesign SA is -88.10%.
The range of the Intrinsic Value is 0.46 - 22.26 EUR
Based on its market price of 14.42 EUR and our intrinsic valuation, Oncodesign SA (ALONC.PA) is overvalued by 88.10%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 0.46 - 22.26 | 1.72 | -88.1% |
| DCF (Growth 10y) | 40.50 - 692.23 | 78.32 | 443.1% |
| DCF (EBITDA 5y) | 14.09 - 26.60 | 22.03 | 52.7% |
| DCF (EBITDA 10y) | 33.15 - 61.96 | 50.17 | 247.9% |
| Fair Value | -4.46 - -4.46 | -4.46 | -130.92% |
| P/E | (5.53) - 3.44 | (3.62) | -125.1% |
| EV/EBITDA | (1.89) - 13.91 | 4.62 | -67.9% |
| EPV | (15.87) - (21.76) | (18.81) | -230.5% |
| DDM - Stable | (12.72) - (181.60) | (97.16) | -773.8% |
| DDM - Multi | 16.90 - 190.14 | 31.22 | 116.5% |
| Market Cap (mil) | 99.44 |
| Beta | 1.16 |
| Outstanding shares (mil) | 6.90 |
| Enterprise Value (mil) | 100.23 |
| Market risk premium | 5.82% |
| Cost of Equity | 6.65% |
| Cost of Debt | 5.00% |
| WACC | 6.17% |